OCT血管成像指标预测糖尿病视网膜病变进展与糖尿病黄斑水肿发生:一项前瞻性研究
该前瞻性观察研究纳入129例糖尿病患者的205只眼,随访至少2年,评估OCT血管成像(OCTA)指标与糖尿病视网膜病变(DR)进展及糖尿病黄斑水肿(DME)发生的关系。结果显示深毛细血管丛(DCP)的FAZ面积、血管密度(VD)和分形维数(FD)预测DR进展,浅毛细血管丛(SCP)的VD预测DME发生,OCTA指标可改善传统危险因素之外的预测判别能力。
要点
- DCP的FAZ面积增大、VD降低和FD降低与DR进展显著相关。
- SCP的VD降低与DME发生相关。
- 在传统危险因素基础上加入OCTA指标可改善DR进展和DME发生的预测判别。
核心结论
- DCP的FAZ面积、VD和FD预测DR进展,而SCP的VD预测DME发生。
- 研究结果提供证据支持OCTA指标在传统危险因素之外改善DR进展和DME发生风险的评估。
研究设计与样本
- 前瞻性观察性研究,纳入129例糖尿病患者的205只眼,随访至少2年。
- 所有参与者使用扫频源OCT设备(DRI-OCT Triton,Topcon公司,日本东京)行OCTA检查。
- 通过IMAGEnet6(基础许可证10)生成SCP和DCP的独立OCTA图像,经质量检查后自动测量FAZ面积、FAZ圆度、VD和FD。
- 主要结局指标为DR进展和DME发生。
主要发现
- 中位随访27.14个月(四分位距24.16-30.41个月)期间,205只眼中28只眼(13.66%)出现DR进展。
- 基线无DME的194只眼中,17只眼(8.76%)发生DME。
- 校正已确立危险因素(基线DR严重程度、糖化血红蛋白、糖尿病病程、年龄和平均动脉压)后,DCP的FAZ面积较大(每增加1个标准差,HR 1.829;95%CI 1.332-2.512)、VD较低(每降低1个标准差,HR 1.908;95%CI 1.303-2.793)和FD较低(每降低1个标准差,HR 4.464;95%CI 1.337-14.903)与DR进展显著相关。
- SCP的VD较低(每降低1个标准差,HR 1.789;95%CI 1.027-4.512)与DME发生相关。
- 与仅含已确立危险因素的模型相比,加入OCTA指标改善了DR进展的预测判别(DCP的FAZ面积,C统计量0.723 vs 0.677,P < 0.001;DCP的VD,C统计量0.727 vs 0.677,P = 0.001;DCP的FD,C统计量0.738 vs 0.677,P < 0.001)和DME发生的预测判别(SCP的VD,C统计量0.904 vs 0.875,P = 0.036)。
关键数值与推荐
- DCP的FAZ面积每增加1个标准差,DR进展的HR为1.829(95%CI 1.332-2.512)。
- DCP的VD每降低1个标准差,DR进展的HR为1.908(95%CI 1.303-2.793)。
- DCP的FD每降低1个标准差,DR进展的HR为4.464(95%CI 1.337-14.903)。
- SCP的VD每降低1个标准差,DME发生的HR为1.789(95%CI 1.027-4.512)。
- 加入OCTA指标后DR进展预测的C统计量:DCP的FAZ面积0.723 vs 0.677(P < 0.001),DCP的VD 0.727 vs 0.677(P = 0.001),DCP的FD 0.738 vs 0.677(P < 0.001);DME发生预测的C统计量:SCP的VD 0.904 vs 0.875(P = 0.036)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To prospectively determine the relationship of OCT angiography (OCTA) metrics to diabetic retinopathy (DR) progression and development of diabetic macular edema (DME). DESIGN: Prospective, observational study. PARTICIPANTS: A total of 205 eyes from 129 patients with diabetes mellitus followed up for at least 2 years. METHODS: All participants underwent OCTA with a swept-source OCT device (DRI-OCT Triton, Topcon, Inc, Tokyo, Japan). Individual OCTA images of superficial capillary plexus (SCP) and deep capillary plexus (DCP) were generated by IMAGEnet6 (Basic License 10). After a quality check, automated measurements of foveal avascular zone (FAZ) area, FAZ circularity, vessel density (VD), and fractal dimension (FD) of both SCP and DCP were then obtained. MAIN OUTCOME MEASURES: Progression of DR and development of DME. RESULTS: Over a median follow-up of 27.14 months (interquartile range, 24.16-30.41 months), 28 of the 205 eyes (13.66%) developed DR progression. Of the 194 eyes without DME at baseline, 17 (8.76%) developed DME. Larger FAZ area (hazard ratio [HR], 1.829 per SD increase; 95% confidence interval [CI], 1.332-2.512), lower VD (HR, 1.908 per SD decrease; 95% CI, 1.303-2.793), and lower FD (HR, 4.464 per SD decrease; 95% CI, 1.337-14.903) of DCP were significantly associated with DR progression after adjusting for established risk factors (DR severity, glycated hemoglobin, duration of diabetes, age, and mean arterial blood pressure at baseline). Lower VD of SCP (HR, 1.789 per SD decrease; 95% CI, 1.027-4.512) was associated with DME development. Compared with the model with established risk factors alone, the addition of OCTA metrics improved the predictive discrimination of DR progression (FAZ area of DCP, C-statistics 0.723 vs. 0.677, P < 0.001; VD of DCP, C-statistics 0.727 vs. 0.677, P = 0.001; FD of DCP, C-statistics 0.738 vs. 0.677, P < 0.001) and DME development (VD of SCP, C-statistics 0.904 vs. 0.875, P = 0.036). CONCLUSIONS: The FAZ area, VD, and FD of DCP predict DR progression, whereas VD of SCP predicts DME development. Our findings provide evidence to support that OCTA metrics improve the evaluation of risk of DR progression and DME development beyond traditional risk factors.
引用
- Sun Z, Tang F, Wong R, et al. OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema: A Prospective Study. Ophthalmology. 2019. PMID: 31358386. doi:10.1016/j.ophtha.2019.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。